Cargando…

Is COPD a Progressive Disease? A Long Term Bode Cohort Observation

BACKGROUND: The Global Initiative for Obstructive Lung Diseases (GOLD) defines COPD as a disease that is usually progressive. GOLD also provides a spirometric classification of airflow limitation. However, little is known about the long-term changes of patients in different GOLD grades. OBJECTIVE: E...

Descripción completa

Detalles Bibliográficos
Autores principales: de-Torres, Juan P., Marín, Jose M., Pinto-Plata, Víctor, Divo, Miguel, Sanchez-Salcedo, Pablo, Zagaceta, Jorge, Zulueta, Javier J., Berto, Juan, Cabrera, Carlos, Celli, Bartolome R., Casanova, Ciro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839642/
https://www.ncbi.nlm.nih.gov/pubmed/27100872
http://dx.doi.org/10.1371/journal.pone.0151856
_version_ 1782428154986496000
author de-Torres, Juan P.
Marín, Jose M.
Pinto-Plata, Víctor
Divo, Miguel
Sanchez-Salcedo, Pablo
Zagaceta, Jorge
Zulueta, Javier J.
Berto, Juan
Cabrera, Carlos
Celli, Bartolome R.
Casanova, Ciro
author_facet de-Torres, Juan P.
Marín, Jose M.
Pinto-Plata, Víctor
Divo, Miguel
Sanchez-Salcedo, Pablo
Zagaceta, Jorge
Zulueta, Javier J.
Berto, Juan
Cabrera, Carlos
Celli, Bartolome R.
Casanova, Ciro
author_sort de-Torres, Juan P.
collection PubMed
description BACKGROUND: The Global Initiative for Obstructive Lung Diseases (GOLD) defines COPD as a disease that is usually progressive. GOLD also provides a spirometric classification of airflow limitation. However, little is known about the long-term changes of patients in different GOLD grades. OBJECTIVE: Explore the proportion and characteristics of COPD patients that change their spirometric GOLD grade over long-term follow-up. METHODS: Patients alive for at least 8 years since recruitment and those who died with at least 4 years of repeated spirometric measurements were selected from the BODE cohort database. We purposely included the group of non survivors to avoid a “survival selection” bias. The proportion of patients that had a change (improvement or worsening) in their spirometric GOLD grading was calculated and their characteristics compared with those that remained in the same grade. RESULTS: A total of 318 patients were included in the survivor and 217 in the non-survivor groups. Nine percent of survivors and 11% of non survivors had an improvement of at least one GOLD grade. Seventy one percent of survivors and non-survivors remained in the same GOLD grade. Those that improved had a greater degree of airway obstruction at baseline. CONCLUSIONS: In this selected population of COPD patients, a high proportion of patients remained in the same spirometric GOLD grade or improved in a long-term follow-up. These findings suggest that once diagnosed, COPD is usually a non-progressive disease.
format Online
Article
Text
id pubmed-4839642
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-48396422016-04-29 Is COPD a Progressive Disease? A Long Term Bode Cohort Observation de-Torres, Juan P. Marín, Jose M. Pinto-Plata, Víctor Divo, Miguel Sanchez-Salcedo, Pablo Zagaceta, Jorge Zulueta, Javier J. Berto, Juan Cabrera, Carlos Celli, Bartolome R. Casanova, Ciro PLoS One Research Article BACKGROUND: The Global Initiative for Obstructive Lung Diseases (GOLD) defines COPD as a disease that is usually progressive. GOLD also provides a spirometric classification of airflow limitation. However, little is known about the long-term changes of patients in different GOLD grades. OBJECTIVE: Explore the proportion and characteristics of COPD patients that change their spirometric GOLD grade over long-term follow-up. METHODS: Patients alive for at least 8 years since recruitment and those who died with at least 4 years of repeated spirometric measurements were selected from the BODE cohort database. We purposely included the group of non survivors to avoid a “survival selection” bias. The proportion of patients that had a change (improvement or worsening) in their spirometric GOLD grading was calculated and their characteristics compared with those that remained in the same grade. RESULTS: A total of 318 patients were included in the survivor and 217 in the non-survivor groups. Nine percent of survivors and 11% of non survivors had an improvement of at least one GOLD grade. Seventy one percent of survivors and non-survivors remained in the same GOLD grade. Those that improved had a greater degree of airway obstruction at baseline. CONCLUSIONS: In this selected population of COPD patients, a high proportion of patients remained in the same spirometric GOLD grade or improved in a long-term follow-up. These findings suggest that once diagnosed, COPD is usually a non-progressive disease. Public Library of Science 2016-04-21 /pmc/articles/PMC4839642/ /pubmed/27100872 http://dx.doi.org/10.1371/journal.pone.0151856 Text en © 2016 de-Torres et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
de-Torres, Juan P.
Marín, Jose M.
Pinto-Plata, Víctor
Divo, Miguel
Sanchez-Salcedo, Pablo
Zagaceta, Jorge
Zulueta, Javier J.
Berto, Juan
Cabrera, Carlos
Celli, Bartolome R.
Casanova, Ciro
Is COPD a Progressive Disease? A Long Term Bode Cohort Observation
title Is COPD a Progressive Disease? A Long Term Bode Cohort Observation
title_full Is COPD a Progressive Disease? A Long Term Bode Cohort Observation
title_fullStr Is COPD a Progressive Disease? A Long Term Bode Cohort Observation
title_full_unstemmed Is COPD a Progressive Disease? A Long Term Bode Cohort Observation
title_short Is COPD a Progressive Disease? A Long Term Bode Cohort Observation
title_sort is copd a progressive disease? a long term bode cohort observation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839642/
https://www.ncbi.nlm.nih.gov/pubmed/27100872
http://dx.doi.org/10.1371/journal.pone.0151856
work_keys_str_mv AT detorresjuanp iscopdaprogressivediseasealongtermbodecohortobservation
AT marinjosem iscopdaprogressivediseasealongtermbodecohortobservation
AT pintoplatavictor iscopdaprogressivediseasealongtermbodecohortobservation
AT divomiguel iscopdaprogressivediseasealongtermbodecohortobservation
AT sanchezsalcedopablo iscopdaprogressivediseasealongtermbodecohortobservation
AT zagacetajorge iscopdaprogressivediseasealongtermbodecohortobservation
AT zuluetajavierj iscopdaprogressivediseasealongtermbodecohortobservation
AT bertojuan iscopdaprogressivediseasealongtermbodecohortobservation
AT cabreracarlos iscopdaprogressivediseasealongtermbodecohortobservation
AT cellibartolomer iscopdaprogressivediseasealongtermbodecohortobservation
AT casanovaciro iscopdaprogressivediseasealongtermbodecohortobservation